Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve Replacement

NCT00944385 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Abnormal Aortic Valve

Interventions

DRUG: ulinastatin

Sponsor

Yonsei University